CAG
SBIO icon

Csenge Advisory Group’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Csenge Advisory Group’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-150
Closed -$4K – 1237
2018
Q3 		$4K Buy
+150
New +$5.69K ﹤0.01% 658

Other funds holding SBIO

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
BFG
Bouchey Financial Group Troy, New York $1.55B AUM 29.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Csenge Advisory Group's SBIO Position: Q4 2018 in Review

Csenge Advisory Group sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q4 2018, closing a stake of 150 shares — an estimated $4K sold.

Csenge Advisory Group first reported a position in SBIO in Q3 2018 and held it in 1 quarter. The position peaked at $4K in Q3 2018. 48 funds tracked by Wall St. Rank hold SBIO as of Q4 2018.

  • Csenge Advisory Group reported no remaining ALPS Medical Breakthroughs ETF position as of Q4 2018 after selling out during the quarter.
  • Csenge Advisory Group sold 150 ALPS Medical Breakthroughs ETF shares in Q4 2018, an estimated $4K.
  • Csenge Advisory Group first reported a position in ALPS Medical Breakthroughs ETF in Q3 2018 and held it in 1 quarter.
  • Csenge Advisory Group's ALPS Medical Breakthroughs ETF position peaked at $4K in Q3 2018.
  • 48 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q4 2018.

Based on Csenge Advisory Group's 13F filing for Q4 2018, filed 7 Feb 2019.